BGB-R046

· BeOne Medicines

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BGB-R046, covering 2026-03-18 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BGB-R046 as Monotherapy and in Combination With Tislelizumab in Solid Tumors [Phase 1]